[{"NetIncomeLoss_1_Q3_USD":-27221000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":13000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":897694.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-297179000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":211000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DueFromRelatedPartiesCurrent_0_Q3_USD":9299000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":1069000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":64892868.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51031003.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5341000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15603000.0,"DepreciationAndAmortization_1_Q3_USD":700000.0,"DepreciationAndAmortization_3_Q3_USD":1900000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":55800000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4173000.0,"MarketableSecuritiesCurrent_0_Q3_USD":401269000.0,"AssetsCurrent_0_Q3_USD":482898000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5674520.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2082000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":4215000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":11030000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":420101000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":10786251.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":28194000.0,"ShareBasedCompensation_3_Q3_USD":6254000.0,"Assets_0_Q3_USD":595070000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":562000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":467692000.0,"CommonStockSharesIssued_0_Q3_shares":66324753.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5144000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1390000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":33314000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-80000.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":63280000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1937000.0,"CommonStockValue_0_Q3_USD":7000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-733000.0,"ProceedsFromStockPlans_3_Q3_USD":1190000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q3_shares":1866174.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":1069000.0,"TemporaryEquityLiquidationPreference_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":2068000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":47618000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":34871000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":95246000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-405000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":421291000.0,"RestrictedCash_0_Q3_USD":1084000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-76174000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-27221000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":137000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":566000.0,"FinanceLeaseLiability_0_Q3_USD":64000.0,"Liabilities_0_Q3_USD":90000000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":736193000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":29669000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":64871000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"GoodwillTranslationAndPurchaseAccountingAdjustments_3_Q3_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"AmortizationOfIntangibleAssets_1_Q3_USD":300000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":801000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-4311000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":4580000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-27301000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-73818000.0,"OtherAssetsNoncurrent_0_Q3_USD":39000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":34232000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":12661000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_Q3_shares":262684.0,"AccountsPayableCurrent_0_Q3_USD":6656000.0,"LiabilitiesCurrent_0_Q3_USD":42384000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":4381000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-75030000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2670000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-27221000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-74688000.0,"Goodwill_0_Q3_USD":14608000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":224000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":7495000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":1069000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":5306220.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":499257000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":1069000.0,"RestrictedCashNoncurrent_0_Q3_USD":1084000.0,"NonoperatingIncomeExpense_3_Q3_USD":1929000.0,"NonoperatingIncomeExpense_1_Q3_USD":330000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":65955000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7459000.0,"NetIncomeLoss_3_Q3_USD":-73955000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":7035000.0,"DividendsCommonStock_3_Q3_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":441000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":7085000.0,"OperatingLeasePayments_1_Q3_USD":600000.0,"CommonStockSharesOutstanding_0_Q3_shares":66324753.0,"OperatingLeasePayments_3_Q3_USD":1900000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":447966.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":65955000.0,"IncreaseDecreaseInDeferredIncomeTaxes_3_Q3_USD":734000.0,"SubleaseIncome_1_Q3_USD":500000.0,"SubleaseIncome_3_Q3_USD":1400000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.071,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":61212000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":5412000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1129000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":49082000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5306220.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2670000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":6254000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":595070000.0,"OperatingLeaseCost_1_Q3_USD":800000.0,"OperatingLeaseCost_3_Q3_USD":1900000.0,"PreferredStockValue_0_Q3_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":7480000.0,"InvestmentIncomeInterest_1_Q3_USD":347000.0,"InvestmentIncomeInterest_3_Q3_USD":1986000.0,"OtherNonoperatingExpense_1_Q3_USD":17000.0,"OtherNonoperatingExpense_3_Q3_USD":57000.0,"OperatingIncomeLoss_1_Q3_USD":-27551000.0,"OperatingIncomeLoss_3_Q3_USD":-76617000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q3_shares":206564.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":22600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":61807.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":14530000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3645000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-382000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":870000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":467481000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1764000.0,"StockholdersEquity_0_Q3_USD":505070000.0,"OtherLiabilitiesCurrent_0_Q3_USD":91000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":64000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-231341000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1089000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.42,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.49,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":21188000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":5046000.0,"OperatingExpenses_1_Q3_USD":40212000.0,"OperatingExpenses_3_Q3_USD":110849000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":266000.0,"ProfitLoss_3_Q3_USD":-73955000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":618000.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]